Bausch Cost Of Revenue vs Total Revenue Analysis

BHC Stock

USD 8.37 0.25 3.08%

Bausch Health financial indicator trend analysis is way more than just evaluating Bausch Health Companies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bausch Health Companies is a good investment. Please check the relationship between Bausch Health Cost Of Revenue and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bausch Health Companies Cost Of Revenue account and Total Revenue. At this time, the significance of the direction appears to have totally related.

The correlation between Bausch Health's Cost Of Revenue and Total Revenue is 0.99. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Bausch Health Companies, assuming nothing else is changed. The correlation between historical values of Bausch Health's Cost Of Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Bausch Health Companies are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Cost Of Revenue i.e., Bausch Health's Cost Of Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Bausch Health Companies income statement and represents the costs associated with goods and services Bausch Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Revenue

Total revenue comprises all receipts Bausch Health Companies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Bausch Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

At present, Bausch Health's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.30, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.

	2021	2022	2023	2024 (projected)
Gross Profit	6.0B	5.8B	6.2B	6.5B
Total Revenue	8.4B	8.1B	8.8B	9.2B

Gross Profit Total Revenue

Bausch Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Inventory	Common Stock Total Equity	Short Term Investments
Total Assets		0.88	0.56	0.72	0.4	0.62	0.88	-0.2	0.33	0.31	0.99	0.47	0.31	0.86	0.74	0.93	0.53	0.63	0.92	0.14	0.63	0.29	0.86	0.58	0.8	-0.15
Short Long Term Debt Total	0.88		0.73	0.89	0.05	0.85	1.0	-0.54	0.64	0.37	0.87	0.45	0.37	0.92	0.67	0.98	0.8	0.63	0.98	0.47	0.73	0.37	0.66	0.83	0.85	0.19
Other Current Liab	0.56	0.73		0.75	-0.29	0.78	0.74	-0.7	0.56	0.05	0.54	0.34	0.05	0.65	0.53	0.71	0.71	0.53	0.72	0.62	0.6	0.07	0.27	0.69	0.69	0.26
Total Current Liabilities	0.72	0.89	0.75		-0.19	0.87	0.87	-0.7	0.71	0.58	0.67	0.2	0.57	0.76	0.63	0.82	0.83	0.66	0.87	0.59	0.83	0.53	0.38	0.82	0.81	0.45
Total Stockholder Equity	0.4	0.05	-0.29	-0.19		-0.22	0.07	0.72	-0.38	-0.12	0.45	-0.03	-0.12	0.21	0.24	0.17	-0.31	0.18	0.11	-0.61	-0.15	-0.07	0.73	-0.21	0.01	-0.67
Property Plant And Equipment Net	0.62	0.85	0.78	0.87	-0.22		0.85	-0.78	0.86	0.28	0.58	0.21	0.28	0.85	0.65	0.78	0.89	0.46	0.81	0.79	0.79	0.27	0.29	0.94	0.86	0.5
Net Debt	0.88	1.0	0.74	0.87	0.07	0.85		-0.52	0.63	0.29	0.88	0.46	0.29	0.93	0.67	0.99	0.8	0.62	0.98	0.47	0.7	0.31	0.68	0.82	0.85	0.17
Retained Earnings	-0.2	-0.54	-0.7	-0.7	0.72	-0.78	-0.52		-0.79	-0.32	-0.14	-0.19	-0.32	-0.41	-0.43	-0.42	-0.74	-0.31	-0.47	-0.88	-0.61	-0.25	0.22	-0.74	-0.64	-0.63
Accounts Payable	0.33	0.64	0.56	0.71	-0.38	0.86	0.63	-0.79		0.33	0.29	0.02	0.33	0.68	0.45	0.55	0.88	0.15	0.59	0.87	0.69	0.45	0.07	0.94	0.66	0.53
Cash	0.31	0.37	0.05	0.58	-0.12	0.28	0.29	-0.32	0.33		0.25	0.04	1.0	0.22	0.32	0.29	0.24	0.42	0.34	0.07	0.51	0.79	0.1	0.28	0.37	0.22
Non Current Assets Total	0.99	0.87	0.54	0.67	0.45	0.58	0.88	-0.14	0.29	0.25		0.46	0.25	0.85	0.72	0.92	0.5	0.62	0.9	0.09	0.53	0.25	0.9	0.54	0.77	-0.18
Non Currrent Assets Other	0.47	0.45	0.34	0.2	-0.03	0.21	0.46	-0.19	0.02	0.04	0.46		0.04	0.4	0.24	0.53	0.18	0.27	0.5	0.02	0.32	-0.17	0.4	0.21	0.3	-0.32
Cash And Short Term Investments	0.31	0.37	0.05	0.57	-0.12	0.28	0.29	-0.32	0.33	1.0	0.25	0.04		0.21	0.32	0.29	0.23	0.42	0.34	0.06	0.51	0.79	0.1	0.28	0.37	0.22
Net Receivables	0.86	0.92	0.65	0.76	0.21	0.85	0.93	-0.41	0.68	0.22	0.85	0.4	0.21		0.66	0.94	0.76	0.44	0.93	0.48	0.71	0.28	0.71	0.85	0.8	0.08
Common Stock Shares Outstanding	0.74	0.67	0.53	0.63	0.24	0.65	0.67	-0.43	0.45	0.32	0.72	0.24	0.32	0.66		0.66	0.49	0.7	0.66	0.32	0.53	0.21	0.52	0.56	0.91	-0.05
Non Current Liabilities Total	0.93	0.98	0.71	0.82	0.17	0.78	0.99	-0.42	0.55	0.29	0.92	0.53	0.29	0.94	0.66		0.73	0.59	0.99	0.38	0.71	0.32	0.77	0.77	0.8	0.03
Other Current Assets	0.53	0.8	0.71	0.83	-0.31	0.89	0.8	-0.74	0.88	0.24	0.5	0.18	0.23	0.76	0.49	0.73		0.35	0.76	0.76	0.73	0.34	0.24	0.93	0.73	0.53
Other Stockholder Equity	0.63	0.63	0.53	0.66	0.18	0.46	0.62	-0.31	0.15	0.42	0.62	0.27	0.42	0.44	0.7	0.59	0.35		0.6	0.05	0.42	0.11	0.45	0.32	0.65	0.06
Total Liab	0.92	0.98	0.72	0.87	0.11	0.81	0.98	-0.47	0.59	0.34	0.9	0.5	0.34	0.93	0.66	0.99	0.76	0.6		0.43	0.79	0.37	0.72	0.8	0.81	0.08
Property Plant And Equipment Gross	0.14	0.47	0.62	0.59	-0.61	0.79	0.47	-0.88	0.87	0.07	0.09	0.02	0.06	0.48	0.32	0.38	0.76	0.05	0.43		0.59	0.17	-0.2	0.78	0.55	0.62
Total Current Assets	0.63	0.73	0.6	0.83	-0.15	0.79	0.7	-0.61	0.69	0.51	0.53	0.32	0.51	0.71	0.53	0.71	0.73	0.42	0.79	0.59		0.47	0.32	0.8	0.67	0.25
Short Term Debt	0.29	0.37	0.07	0.53	-0.07	0.27	0.31	-0.25	0.45	0.79	0.25	-0.17	0.79	0.28	0.21	0.32	0.34	0.11	0.37	0.17	0.47		0.21	0.38	0.27	0.12
Intangible Assets	0.86	0.66	0.27	0.38	0.73	0.29	0.68	0.22	0.07	0.1	0.9	0.4	0.1	0.71	0.52	0.77	0.24	0.45	0.72	-0.2	0.32	0.21		0.32	0.48	-0.5
Inventory	0.58	0.83	0.69	0.82	-0.21	0.94	0.82	-0.74	0.94	0.28	0.54	0.21	0.28	0.85	0.56	0.77	0.93	0.32	0.8	0.78	0.8	0.38	0.32		0.78	0.42
Common Stock Total Equity	0.8	0.85	0.69	0.81	0.01	0.86	0.85	-0.64	0.66	0.37	0.77	0.3	0.37	0.8	0.91	0.8	0.73	0.65	0.81	0.55	0.67	0.27	0.48	0.78		0.24
Short Term Investments	-0.15	0.19	0.26	0.45	-0.67	0.5	0.17	-0.63	0.53	0.22	-0.18	-0.32	0.22	0.08	-0.05	0.03	0.53	0.06	0.08	0.62	0.25	0.12	-0.5	0.42	0.24

Click cells to compare fundamentals

Bausch Health Account Relationship Matchups

Bausch Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.9B	31.2B	29.2B	25.7B	27.4B	14.9B
Short Long Term Debt Total	25.9B	24.0B	22.7B	20.8B	22.4B	23.5B
Other Current Liab	2.1B	4.6B	4.8B	2.9B	3.1B	3.2B
Total Current Liabilities	6.2B	4.9B	5.2B	3.9B	4.3B	4.5B
Total Stockholder Equity	1.1B	535M	(106M)	(692M)	(1.0B)	(970.9M)
Property Plant And Equipment Net	1.5B	1.6B	1.6B	1.6B	1.7B	1.8B
Net Debt	22.7B	23.3B	22.1B	20.2B	21.4B	22.5B
Retained Earnings	(7.5B)	(8.0B)	(9.0B)	(9.2B)	(9.8B)	(9.3B)
Accounts Payable	503M	337M	407M	521M	719M	755.0M
Cash	3.2B	605M	582M	564M	947M	502.7M
Non Current Assets Total	26.9B	25.9B	23.6B	21.4B	21.8B	12.7B
Non Currrent Assets Other	411M	664M	340M	326M	307M	236.2M
Cash And Short Term Investments	3.2B	605M	582M	564M	947M	506.0M
Net Receivables	1.8B	1.6B	1.8B	1.8B	2.0B	2.1B
Common Stock Shares Outstanding	352.1M	355M	358.9M	362M	364.9M	246.3M
Liabilities And Stockholders Equity	33.9B	31.2B	29.2B	25.7B	27.4B	14.9B
Non Current Liabilities Total	26.5B	25.7B	24.0B	21.5B	23.1B	24.3B
Other Current Assets	779M	855M	720M	803M	1.1B	1.2B
Other Stockholder Equity	429M	454M	462M	159M	214M	203.3M
Total Liab	32.7B	30.6B	29.2B	25.4B	27.4B	28.8B
Property Plant And Equipment Gross	1.5B	1.6B	3.4B	3.5B	3.8B	4.0B
Total Current Assets	7.0B	5.3B	5.6B	4.2B	5.6B	5.9B
Accumulated Other Comprehensive Income	(2.1B)	(2.1B)	(1.9B)	(2.1B)	(1.9B)	(1.8B)
Short Term Debt	1.2B	52M	49.9M	482M	450M	472.5M
Intangible Assets	10.2B	8.4B	6.9B	5.8B	6.5B	5.8B
Inventory	1.1B	1.1B	993M	1.1B	1.5B	1.6B
Common Stock Total Equity	10.2B	10.2B	10.3B	10.4B	11.9B	7.0B
Common Stock	10.2B	10.2B	10.3B	10.4B	10.4B	6.1B
Other Liab	1.6B	1.5B	1.2B	967M	1.1B	1.3B
Current Deferred Revenue	2.4B	(52M)	(49.9M)	2.1B	2.4B	2.5B
Other Assets	1.8B	2.8B	2.3B	2.3B	2.6B	2.7B
Long Term Debt	24.7B	23.9B	22.7B	20.3B	21.9B	14.0B
Good Will	13.1B	13.0B	12.5B	11.5B	11.2B	7.2B
Property Plant Equipment	1.5B	1.6B	1.6B	1.8B	2.1B	2.2B
Net Tangible Assets	(22.3B)	(21.0B)	(19.5B)	(18.0B)	(16.2B)	(17.0B)
Noncontrolling Interest In Consolidated Entity	73M	70M	72M	952M	1.1B	1.1B
Retained Earnings Total Equity	(7.5B)	(8.0B)	(9.0B)	(9.2B)	(8.3B)	(7.9B)
Long Term Debt Total	24.7B	23.9B	22.7B	20.3B	23.4B	21.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:

How To Invest In Bausch

Details

Is Bausch Stock a good investment?

Details

What is Bausch Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.61)

Earnings Share

(0.48)

Revenue Per Share

25.794

Quarterly Revenue Growth

0.122

Return On Assets

0.0415

The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bausch Cost Of Revenue vs Total Revenue Analysis

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Total Revenue

Bausch Health fundamental ratios Correlations

Bausch Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bausch Health fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total

Property Plant And Equipment Gross	- 0.88	Retained Earnings
Accounts Payable	- 0.79	Retained Earnings
Retained Earnings	- 0.78	Property Plant And Equipment Net
Inventory	- 0.74	Retained Earnings
Other Current Assets	- 0.74	Retained Earnings
Retained Earnings	- 0.7	Total Current Liabilities